We have shown that progesterone in the form of 17-OHPC administered after placental ischemia improved ET-1, uterine artery resistance, intrauterine growth restriction (IUGR), and blood pressure in rat models of PE [38,39], thereby further establishing proof of concept supporting that progesterone could be a beneficial treatment for PE. The gene discussed is EDN1; the disease is fetal growth restriction.